The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More Cost-Effective Than Thought, And May Save Money-Reference-Cited by-同舟云学术

The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More Cost-Effective Than Thought, And May Save Money

Published:2011-07 Issue:7 Volume:30 Page:1351-1357
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Shrank William H.¹,Choudhry Niteesh K.²,Liberman Joshua N.³,Brennan Troyen A.⁴

Affiliation:

1. William H. Shrank ( ) is the principal investigator and director of the CVS Caremark Harvard Partnership to Improve Medication Adherence and an associate physician at Brigham and Women’s Hospital, in Boston, Massachusetts.

2. Niteesh K. Choudhry is an assistant professor at Harvard Medical School and an associate physician at Brigham and Women’s Hospital.

3. Joshua N. Liberman is vice president of research operations at the Center for Health Research, Geisinger Health System, in Danville, Pennsylvania.

4. Troyen A. Brennan is the executive vice president and chief medical officer at CVS Caremark, in Woonsocket, Rhode Island.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference16 articles.

1. Persons With Chronic Conditions

2. Can Disease Management Reduce Health Care Costs By Improving Quality?

3. Does Preventive Care Save Money? Health Economics and the Presidential Candidates

4. The Impact of Prevention on Reducing the Burden of Cardiovascular Disease

5. Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactive Data Science Hub with Chatbot;2024 Second International Conference on Emerging Trends in Information Technology and Engineering (ICETITE);2024-02-22

2. Trends in pharmaceutical expenditure in the Taiwan National Health Insurance database at different hospital levels;Journal of Comparative Effectiveness Research;2023-02

3. A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt;Journal of Pharmaceutical Policy and Practice;2022-03-01

4. Signs of neuroinflammation outweigh neurodegeneration as predictors for early conversion to MS;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2021-10-05

5. Generic drug prescribing in primary care: A nationwide analysis;International Journal of Clinical Practice;2021-05-09